51 min listen
A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow
A Non-Profit Biotech Model; Therapies for Rare Diseases - Dr. Ashley Winslow
ratings:
Length:
49 minutes
Released:
Sep 9, 2023
Format:
Podcast episode
Description
This episode has two parts. The first part discusses how Odylia Therapeutics is addressing rare disease, using a novel non-profit model. The second half address two rare genetic eye diseases and the approaches being designed to address them. Dr. Ashley Winslow, CEO/CSO of Odylia, describes how a non-profit is well suited to address these rare diseases, using strategies that leverage capacities in rare disease patient communities coupled to their expertise in drug discovery.
Released:
Sep 9, 2023
Format:
Podcast episode
Titles in the series (100)
An Experiment You can Do With Us; Sugar Beet Breeding and Biology: This eThis episode of Talking Biotech invites you to be the investigator and data collector. The internet is littered with images that claim animals will not eat GMO corn, which is curious because 80% of it goes to animal feed. We have arranged to test by Talking Biotech with Dr. Kevin Folta